Fort Lauderdale-based medical device maker Mako Surgical (NSDQ:MAKO) closed the books on a $40 million funding round with an extra $3 million in net proceeds, the company announced.
Mako said last week that the offering, priced at $13.15 per share for more than 3 million shares, would go toward "commercialization infrastructure" and to cover other corporate expenses.
The company said at the time that the funding rounds could reach $43 million total if underwriter Piper Jaffray exercised a 456,000-share over-allotment, which it did.
The net proceeds of the offering, which closed on schedule on Nov. 19, amounted to $43 million after deducting underwriting discounts, commissions and estimated offering expenses, according to a press release.
MAKO shares were up 0.9% to $14.13 as of about 9:45 a.m. this morning.
